Diagnosis, prevalence, and risk factors of atrophic gastritis


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Atrophic gastritis as a precancerous disease is crucial for the early diagnosis and prevention of gastric cancer. The risk factors for atrophic gastritis and gastric cancer are Helicobacter pylori (Hp) infection, male sex, tobacco smoking, the consumption of salted foods and processed meat, as well as hereditary load. The early detection of gastric mucosal atrophy and Hp eradication are of importance in preventing gastric cancer.

全文:

受限制的访问

作者简介

V. Tsukanov

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences

Email: gastro@impn.ru
Professor, MD Krasnoyarsk

A. Vasyutin

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk

Yu. Tonkikh

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk

O. Peretyatko

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk

参考

  1. Malfertheiner P., Chan F., McColl K. Peptic ulcer disease // Lancet. - 2009; 374 (9699): 1449-61. doi: 10.1016/S0140-6736(09)60938-7.
  2. Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. - 2015; 148 (4): 719-31. DOI: 10.1053/j. gastro.2015.01.040.
  3. Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. - 2015; 64 (9): 1353-67. DOI: 10.1136/ gutjnl-2015-309252.
  4. Malfertheiner P., Megraud F., O'Morain C. et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report // Gut. - 2017; 66 (1): 6-30. doi: 10.1136/gutjnl- 2016-312288.
  5. Rugge M., Genta R., Graham D. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment // Gut. - 2016; 65 (5): 721-5. DOI: 10.1136/ gutjnl-2015-310846.
  6. Misiewicz J. The Sydney System: a new classification of gastritis. Introduction // J. Gastroenterol. Hepatol. - 1991; 6 (3): 207-8.
  7. Dixon M., Genta R., Yardley J. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 // Am. J. Surg. Pathol. - 1996; 20 (10): 1161-81.
  8. Rugge M., Correa P., Di Mario F. et al. OLGA staging for gastritis: a tutorial // Dig. Liver Dis. - 2008; 40 (8): 650-8. doi: 10.1016/j.dld.2008.02.030.
  9. Dinis-Ribeiro M., Areia M., de Vries A. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) // Endoscopy. - 2012; 44 (1): 74-94. doi: 10.1055/s-0031-1291491.
  10. Liu Y., Ponsioen C., Waverling G. et al. Helicobacter pylori gastritis - a global view. In: Hunt R.H., Tytgat G.N.J. (eds) Helicobacter pylori / Dordrecht: Kluwer academic publishers, 2000; p. 213-20. doi: 10.1007/978-94-011-3927-4_23.
  11. Штыгашева О.В., Цуканов В.В. Ассоциация CаgA и VacA штаммов Helicobacter pylori и язвенной болезни в организованной популяции г. Абакана // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2004; 14 (2): 84-7.
  12. Агеева Е.С., Штыгашева О.В., Рязанцева Н.В. и др. Молекулярно-генетические факторы, влияющие на исход инфицирования Helicobacter pylori у жителей Республики Хакасия // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2010; 20 (4): 16-21.
  13. Lombardo L., Leto R., Molinaro G. et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test // Clin. Chem. Lab. Med. - 2010; 48 (9): 1327-32. doi: 10.1515/CCLM.2010.256.
  14. Leja M., Cine E., Rudzite D. et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia // Eur. J. Gastroenterol. Hepatol. - 2012; 24(12): 1410-7. doi: 10.1097/MEG.0b013e3283583ca5.
  15. Telaranta-Keerie A., Kara R., Paloheimo L. et al. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints // Scand. J. Gastroenterol. - 2010; 45 (9): 1036-41. doi: 10.3109/00365521.2010.487918.
  16. Benberin V., Bektayeva R., Karabayeva R. et al. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers // Anticancer Res. - 2013; 33 (10): 4595-602.
  17. Toyoda K., Furusyo N., Ihara T. et al. Serum pepsinogen and Helicobacter pylori infection - a Japanese population study // Eur. J. Clin. Microbiol. Infect. Dis. - 2012; 31 (9): 2117-24. doi: 10.1007/s10096-011-1543-0.
  18. Zou D., He J., Ma X. et al. Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC) // J. Gastroenterol. Hepatol. - 2011; 26 (5): 908-15. doi: 10.1111/j.1440-1746.2010.06608.x.
  19. Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 22 (4): 27-31.
  20. Решетников О.В., Курилович С.А., Кротов С.А. и др. Распространенность атрофического гастрита в разных популяциях Сибири по данным серологического исследования // Клин. медицина. - 2008; 86 (7): 35-8.
  21. Леонтьева Н.И. Грачева Н.М., Новикова Л.И. Клиническая оценка диагностики хеликобактериоза у больных с хронической патологией желудочнокишечного тракта диагностической тест-системой «Гастропанель» // Эксперим. и клинич. гастроэнтерол. - 2009; (2, прил. 1): 80.
  22. Roman L., Lukyanchuk R., Sablin O. et al. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg // Anticancer Res. - 2016; 36 (8): 412938.
  23. Song J., Kim Y., Heo N. et al. High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia // Cancer Epidemiol. Biomarkers Prev. - 2017; 26 (7): 1133-8. doi: 10.1158/1055-9965.EPI-16-1024.
  24. Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. - 2015; 148 (4): 719-31. DOI: 10.1053/j. gastro.2015.01.040.
  25. Fuccio L., Zagari R., Eusebi L. et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? // Ann. Intern. Med. -2009; 151 (2): 121-8. doi: 10.7326/0003-4819-151-2-200907210-00009.
  26. Wang J., Xu L., Shi R. et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis // Digestion. - 2011; 83 (4): 253-60. doi: 10.1159/000280318.
  27. Lee Y., Chen T., Chiu H. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention // Gut. -2013; 62 (5): 676-82. doi: 10.1136/gutjnl-2012-302240.
  28. Lee Y., Chiang T., Chou C. et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis // Gastroenterology. - 2016; 150 (5): 1113-24. DOI: 10.1053/j. gastro.2016.01.028.
  29. Malfertheiner P., Megraud F., O'Morain C. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report // Gut. - 2007; 56 (6): 772-81. doi: 10.1136/gut.2006.101634.
  30. Цуканов В.В., Амельчугова О.С., Каспаров Э.В. и др. Роль эрадикации Helicobacter pylori в профилактике рака желудка // Тер. арх. - 2014; 86 (8): 124-7.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##